164 related articles for article (PubMed ID: 8340529)
1. Autoantibodies in scleroderma.
Fritzler MJ
J Dermatol; 1993 May; 20(5):257-68. PubMed ID: 8340529
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
Reimer G
Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody to centromere (kinetochore) in scleroderma sera.
Moroi Y; Peebles C; Fritzler MJ; Steigerwald J; Tan EM
Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1627-31. PubMed ID: 6966403
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody profile in systemic sclerosis.
Behmanesh F; Amin R; Khajedaluee M; Fritzler MJ
Acta Med Iran; 2010; 48(1):12-20. PubMed ID: 21137663
[TBL] [Abstract][Full Text] [Related]
6. [Types of anticellular structure antisera in scleroderma patients].
Ni ZM
Zhonghua Yi Xue Za Zhi; 1993 May; 73(5):270-2, 318. PubMed ID: 8221243
[TBL] [Abstract][Full Text] [Related]
7. Scl-86, a marker antigen for diffuse scleroderma.
van Venrooij WJ; Stapel SO; Houben H; Habets WJ; Kallenberg CG; Penner E; van de Putte LB
J Clin Invest; 1985 Mar; 75(3):1053-60. PubMed ID: 3980727
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in scleroderma.
Pollard KM; Reimer G; Tan EM
Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161
[TBL] [Abstract][Full Text] [Related]
9. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex.
Yang JM; Hildebrandt B; Luderschmidt C; Pollard KM
Arthritis Rheum; 2003 Jan; 48(1):210-7. PubMed ID: 12528121
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.
Ulanet DB; Wigley FM; Gelber AC; Rosen A
Arthritis Rheum; 2003 Feb; 49(1):85-92. PubMed ID: 12579598
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to fibroblasts in scleroderma.
Brentnall TJ; Kenneally D; Barnett AJ; de Aizpurua HJ; Lolait SJ; Ashcroft R; Toh BH
J Clin Lab Immunol; 1982 May; 8(1):9-12. PubMed ID: 7047748
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations.
Van Eenennaam H; Vogelzangs JH; Bisschops L; Te Boome LC; Seelig HP; Renz M; De Rooij DJ; Brouwer R; Pluk H; Pruijn GJ; Van Venrooij WJ; Van Den Hoogen FH
Clin Exp Immunol; 2002 Dec; 130(3):532-40. PubMed ID: 12452846
[TBL] [Abstract][Full Text] [Related]
13. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
Johanet C; Agostini MM; Vayssairat M; Abuaf N
Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
[TBL] [Abstract][Full Text] [Related]
14. Autoepitope mapping of the centrosome autoantigen PCM-1 using scleroderma sera with anticentrosome autoantibodies.
Bao L; Zimmer WE; Balczon R
Autoimmunity; 1995; 22(4):219-28. PubMed ID: 8781714
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in scleroderma and polymyositis: an update.
McCarty GA
Semin Dermatol; 1991 Sep; 10(3):206-16. PubMed ID: 1931570
[TBL] [Abstract][Full Text] [Related]
16. A cross-reactive idiotype in scleroderma.
Vázquez-Abad D; Tian L; Zanetti M; Rothfield NF
Clin Exp Immunol; 1997 Jun; 108(3):420-7. PubMed ID: 9182886
[TBL] [Abstract][Full Text] [Related]
17. [Antinucleolar antibodies in diagnostics of antiphospholipid syndrome].
Zabek J; Palacz A; Pyka J; Krzewska I
Pol Arch Med Wewn; 2008; 118 Suppl():25-30. PubMed ID: 19562966
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody to RNA polymerase I in scleroderma sera.
Reimer G; Rose KM; Scheer U; Tan EM
J Clin Invest; 1987 Jan; 79(1):65-72. PubMed ID: 2432091
[TBL] [Abstract][Full Text] [Related]
19. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
[TBL] [Abstract][Full Text] [Related]
20. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma).
Reimer G; Steen VD; Penning CA; Medsger TA; Tan EM
Arthritis Rheum; 1988 Apr; 31(4):525-32. PubMed ID: 2451921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
